Abstract
YdiV is a negative regulator of cell motility. It interacts with FlhD4C2 complex, a product of flagellar master operon, which works as the transcription activator of all other flagellar operons. Here, we report the crystal structures of YdiV and YdiV2–FlhD2 complex at 1.9 Å and 2.9 Å resolutions, respectively. Interestingly, YdiV formed multiple types of complexes with FlhD4C2. YdiV1–FlhD4C2 and YdiV2–FlhD4C2 still bound to DNA, while YdiV3–FlhD4C2 and YdiV4–FlhD4C2 did not. DNA bound FlhD4C2 through wrapping around the FlhC subunit rather than the FlhD subunit. Structural analysis showed that only two peripheral FlhD subunits were accessible for YdiV binding, forming the YdiV2–FlhD4C2 complex without affecting the integrity of ring-like structure. YdiV2–FlhD2 structure and the negative staining electron microscopy reconstruction of YdiV4–FlhD4C2 suggested that the third and fourth YdiV molecule bound to the FlhD4C2 complex through squeezing into the ring-like structure of FlhD4C2 between the two internal D subunits. Consequently, the ring-like structure opened up, and the complex lost DNA-binding ability. Thus, YdiV inhibits FlhD4C2 only at relatively high concentrations.
INTRODUCTION
The formation and assembly of the flagellum, an essential motility apparatus in many bacteria, are well organized and hierarchically processed (1,2). At the top of the hierarchy is the flhDC operon, whose expression is required for the transcription of class II flagellar operons. The products of flhDC operon, FlhD and FlhC, form a heterohexamer (D4C2) to bind to the upstream of class II promoters and promote class II genes transcription (3). The DNA fragment bound by FlhD4C2, called the FlhD4C2 box, contains two 17- or 18-bp inverted repeats with a 10- or 11-bp spacer between them (4). It has been reported that the FlhC subunit interacts with DNA, while the FlhD subunit strengthens the specificity to the FlhD4C2 box and the stability of the protein–DNA complex (5,6). The two zinc-binding sites are located at both sides of the FlhDC heterohexamer complex, respectively. However, Wang et al. (7) have suggested that the DNA may mainly wrap around the FlhD subunits when FlhD4C2 activates the downstream gene transcription. The discrepancy is which subunit DNA wraps around.
The expression of flagellar genes is regulated on several levels by a series of regulators. The AMP-catabolite gene activator protein (CAP) complex activates flhDC transcription at high intracellular cAMP levels (8). Three other proteins RcsB, H-NS and RtsB regulate cell motility by interacting with the flhDC promoter. CsrA, an RNA-binding protein, up-regulates flagellar gene expression through enhancing translation of flhDC mRNA, while DnaK, a chaperone protein, converts native FlhDC into a functional transcriptional regulator. FlhD4C2 can be degraded by ClpXP protease (9–12). Recently, two other proteins, FliT and YdiV, are recognized as negative regulators that prevent FlhD4C2 from binding to its target DNA by direct protein–protein interactions (13,14). Interestingly, the two regulators exert their inhibitory roles in different modes, with FliT binding to the FlhC subunit and YdiV to the FlhD subunit. Although the crystal structure of FliT has been determined, it is still unclear how it shuts down the transcription through interaction with FlhD4C2 (15).
YdiV shares weak sequence similarity with typical EAL proteins. The EAL proteins, named by their characteristic motif ‘EAL’ (Glu-Ala-Leu), are often responsible for degradation of second signaling messenger bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) (16–18). The molecule regulates the switch between the motile and sessile lifestyles of bacteria: high intracellular concentrations of c-di-GMP promote biofilm formation, whereas low concentrations lead to motility. Therefore, the in vivo function of EAL proteins is predicted as stimulating bacterium motility by down-regulating the c-di-GMP level, like YhjH from Escherichia coli and STM1827 from Salmonella (19–21). Ten conserved residues of EAL proteins are essential for their catalytic activity and c-di-GMP binding (18,22,23).
YdiV does not show catalytic activity to c-di-GMP and cannot bind c-di-GMP (24,25). Eight out of the 10 conserved catalytic residues are not preserved in YdiV (23). Interestingly, unlike typical EAL proteins, YdiV inhibits the cell motility rather than stimulating motility (26,27). Wada et al. (14) demonstrated that Salmonella YdiV functions as a novel anti-FlhD4C2 factor, which regulates bacterium motility and is responsible for nutritional control of the flagellum regulation in Salmonella. Under low-nutrient conditions, Salmonella is known to repress flagellum synthesis, while E. coli up-regulates flagellum synthesis (14,28). The different responses between Salmonella and E. coli raise the question whether YdiV in E. coli functions in the same way as its homologue from Salmonella, despite the fact that the sequence identity between them is 52%. Recently, Wada et al. (29) reported that E. coli YdiV can also inhibit motility and flagellum production by interacting with FlhD4C2, indicating that the inhibitory mechanisms of YdiV to FlhDC are similar between E. coli and Salmonella. Moreover, YdiV mediates the interaction between the two quorum sensing systems in E. coli in cooperation with its transcription activator SdiA and cAMP concentrations (30). Recently, Salmonella YdiV has been highlighted to be required in the host–pathogen interactions, impacting Salmonella virulence by inhibiting flagellar genes in systemic tissues. YdiV mutant strain is vulnerable to caspase-1-mediated colonization restriction by lacking the function of fully repressed flagellin expression in systemic tissues (24,31). The regulation of virulence in Salmonella seems to be also caused by YdiV’s inhibition to flagellar biogenesis. However, the detailed molecular mechanism by which YdiV negatively regulates the transcriptional activity of FlhD4C2 remains unclear.
In this article, we report the crystal structures of YdiV at 1.9 Å resolution and the YdiV2–FlhD2 complex at 2.9 Å resolution. Our structure analyses combined with biochemistry studies and reconstruction of YdiV4–FlhD4C2 structure via negative staining electron microscopy provide a clear regulatory mechanism that stoichiometric binding of YdiV to FlhD in the FlhD4C2 complex results in the opening of the ring-like structure of FlhD4C2 with consequent loss of DNA binding. Very recently, Takaya et al. (32) have reported similar results that Salmonella YdiV forms multiple types of complexes with FlhD4C2 and the L22H substitution in FlhD prevents the interaction with YdiV. Our structure analysis gives us a clear explanation to those phenomena.
MATERIALS AND METHODS
Protein expression and purification
The ydiV and flhD genes were cloned into pET29b and pGL01 vector. YdiV was expressed in E. coli BL21(DE3) and purified by Ni2+-NTA affinity column, ion exchange column Source-Q and Superdex 200 successively. Se-Met-YdiV was expressed in E. coli BL21(DE3) using M9 medium. l-Seleno-methionnine was added to the culture when OD600 reached 0.5. The purification procedure of Se-Met-YdiV was the same with native YdiV. The YdiV–FlhD complex was obtained by co-expression in E. coli BL21 (DE3) with the same expression condition of YdiV. After Ni2+-NTA affinity column, the YdiV–FlhD complex was lysed by 0.25 mg/ml trypsin for 30 min and purified by ion exchange column Source-Q and Superdex 200 chromatography immediately. Whole flhDC operon was cloned into pET21b in which FlhC contained a C-terminal His-tag. The FlhD4C2 complex was obtained by co-expression.
Site-directed mutagenesis
Mutants were constructed using the two-step PCR strategy and cloned into pGL01, respectively. Three YdiV mutants (A184E, F181A and F181A-A184E) were also cloned into pGEX-6P-1 and transformed into Escherichia coli str. K-12 substr. MG1655 for further motility studies.
Crystallization and structure determination
Crystals were grown using hanging drop vapor diffusion at 20°C. Both native and anomalous diffraction data were collected at Shanghai Synchrotron Radiation facility (SSRF) beamline BL17u1. The data sets were processed using the HKL2000 software suite (33). Structure of YdiV alone was solved by single anomalous dispersion phasing. Five Se sites were found using the program SOLVE (34). Initial single anomalous dispersion phases were then improved and the chain was automatically traced using the program RESOLVE (35). The atomic model was built using COOT (36) and refined using PHENIX (37). The structure of YdiV–FlhD was determined at 2.9 Å resolution, with the molecular replacement approach using PHASER (38) with the FlhD structure (PDB code: 1G8E) and our YdiV structure as searching models. The model building and structure refinement of YdiV–FlhD follow the same procedure as YdiV structure. Data collection and structure refinement statistics are summarized in Supplementary Table S1. Structural figures were generated using PyMol (http://www.pymol.org).
Size-exclusion chromatography
Two proteins (YdiV and FlhD4C2) were mixed in different mixing ratio (5:1, 1:1) for 10 min at room temperature and injected to size-exclusion chromatography using a Superdex 200 column. All data were processed by Origin.
Protein pull-down assay
Bait proteins were prepared as described above. His-tag of prey proteins were removed by PPase during purification. Bait protein was immobilized onto Ni2+-NTA beads and then incubated prey protein at 4°C for 30 min. The mixture was washed three times using buffer containing 25 mM Tris–HCl (pH 8.0) and 100 mM NaCl. Proteins were eluted with elution buffer containing 25 mM Tris–HCl (pH 8.0), 100 mM NaCl and 250 mM imidazole. Then the elution samples were analyzed by SDS–PAGE with Coomassie blue staining. Prey proteins were incubated with Ni2+-NTA beads alone as a negative control.
Electrophoretic mobility shift assay experiment
A 49-bp DNA fragment of the flhB promoter was synthesized as target DNA. Ten picomoles of DNA was pre-incubated with different ratios of proteins for 10 min in a reaction buffer containing 20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 1 mM MgCl2, 1 mM ZnCl2 and 4%(v/v) glycerol. Then samples were analyzed using a native 5% polyacrylamide gel and dyed by ethidium bromide. Some gels were also dyed by Coomassie brilliant blue.
Swarming motility assay
Motility was evaluated using 0.3% or 0.5% soft agar plates according to a reported method (26,27). Briefly, single colonies were poked into the plates using toothpicks and incubated for 6 h at 37°C, and then the diameter of motility was measured. For motility assays with the pGEX construct, colonies were picked from plates that contained 1 mM isopropyl β-d-1-thiogalactopyranoside. At least six independent colonies were checked for each strain.
Negative staining EM sample preparation and single-particle image analysis
The gel filtration purified FlhDC–YdiV complex was diluted to 50–80 nM and immediately applied to glow-discharged holey carbon grids covered with a layer of thin carbon film. After 1 min, the samples were stained consecutively in three droplets of 2% (w/v) uranyl acetate solution for a total of 2 min, and the remaining stain was removed by gentle blotting with filter paper. The samples were examined using an FEI F20 electron microscope operated at 200 kV acceleration voltage using a nominal magnification of 50 000. Images were recorded on a 4 k × 4 k Ultrascan4000 CCD camera (Gatan) using low-dose mode with an exposure dose of ∼40 e/Å2. The defocus used to collect the raw image was −1.2 to −1.5 μm. The electron micrographs had a pixel size of 2.2 Å and were directly used for image processing. We used EMAN2 package to perform semi-automatic particle picking and to box the particles from the raw micrographs into boxes of 80 × 80 square pixels (39). The particles were normalized and high- and low-pass filtered prior all image processing procedures. About 30 000 raw particles of FlhDC–YdiV complexes were collected for two-dimensional reference-free alignment and classification using multivariate statistical analysis and multi-reference alignment in IMAGIC-4D (40) to a total of 200 classes.
RESULTS
Crystal structure of YdiV
The YdiV structure was solved using selenium single-wavelength anomalous diffraction at 1.9 Å resolution. The final model of YdiV contains two protein molecules (Mol A and Mol B) per asymmetric unit. The YdiV monomer consists of 10 α-helices, 8 β-strands and 2 short 310 helices, which exhibits a modified TIM-like barrel fold (Figure 1A and B). Although YdiV shares low-sequence identities with other EAL domain proteins (below 20% for the full length), the topology of the structures is the same. The lowest root mean square deviation of the superimposed Cα atoms between YdiV and its homologues is 3.0 Å (more than 223 Cα-positions of TBD1265, PDB code:3N3T). YdiV’s eight β-strands match well with those of TBD1265; in contrast, nearly all Cα atoms of the 10 α-helices show great spatial deviation. Particularly, the α8-helix of YdiV, which is essential for dimerization in other EAL structures, undergoes dramatic transformation (Figure 1C). Notably, although YdiV loses most of the residues coordinating with c-di-GMP, a similar groove that is responsible for c-di-GMP binding in other EAL structures is still retained. Interestingly, a phosphate and a glycerol molecule appear in this groove in contact with Thr32, His33, Phe34, Thr45, Gln64, Gln85 and some water molecules (Figure 1D). They are partially parallel to the c-di-GMP molecule in TBD1265, implicating that other small molecules with similar structures may bind to YdiV within this groove and play a regulatory role to the function of YdiV.
The interaction style of YdiV’s Mol A and Mol B is completely different from other dimerized EAL structures, such as Blrp1, YkuI, TBD1265, LapD and FimX (23,41–44). The Mol A and Mol B’s α8-helices, whose corresponding helices mediates the dimerization in Blrp1, YkuI, LapD and TBD1265 structures, are far away from each other (Supplementary Figure S1). The interaction interface between the two monomers is also smaller than that of the standard EAL protein dimers. We therefore speculate that YdiV does not form stable dimer in solution. This was confirmed by size-exclusion chromatography of purified YdiV (Supplementary Figure S2). The inability for YdiV to dimerize indicates its function in a unique way distinct from other EAL proteins.
E. coli YdiV forms ternary complex with FlhDC through interacting with FlhD
YdiV is known to interact with FlhD4C2 in Salmonella (2011). To determine whether YdiV functions in the same way in E. coli, we co-expressed three groups of proteins: YdiV/FlhD-His, YdiV/FlhC-His and YdiV/FlhDC-His in E. coli BL21(DE3). YdiV formed stable complexes with both FlhD and FlhDC, but not with FlhC alone (Supplementary Figure S3A, B and C). These results indicate that YdiV binds to the FlhD4C2 complex through direct interaction with the FlhD subunit, and the binding of YdiV does not dissociate the FlhD and FlhC subunits in an FlhD4C2 complex. This is consistent with the report of Wada et al. Size-exclusion chromatography also confirmed that YdiV can form a stable ternary complex with FlhD4C2 (Supplementary Figure S3D). We further characterized the minimal YdiV-interacting domain in FlhD using purified recombinant proteins from E. coli. Four fragments of FlhD (1–71aa, 1–82aa, 1–98aa and 1–106aa) were tested with YdiV (Supplementary Figure S4). All fragments can form stable complex with YdiV in the nickel column pull-down assay, suggesting that the C-terminus of FlhD is not essential for YdiV binding, inconsistent with the Salmonella YdiV/FlhD interaction reported by Wade et al. (14).
YdiV prevents FlhDC from binding to DNA in a quantity-dependent manner
To validate whether YdiV functions as an anti-FlhD4C2 factor and inhibits the DNA-binding activity of FlhD4C2 in E. coli, we performed a series of electrophoretic mobility shift assays (EMSAs) with a 49-bp promoter region of flhB that was proven to bind to FlhD4C2 (Figure 2A). We first added 5-fold excessive amount of purified YdiV protein into the DNA-binding system by FlhDC. As expected, no FlhDC–DNA complex was detected, indicating that YdiV does inhibit DNA binding by FlhD4C2 (Figure 2B). We then tested FlhDC’s DNA-binding behavior at different molar ratios of YdiV and FlhD4C2 (Figure 2C). Clear DNA shift can be detected when the molar ratio of YdiV:FlhD4C2 is below 2.5, whereas no shift happens upon the ratio exceeding 3. A surprising phenomenon was at the molar ratio of YdiV:FlhD4C2 below 2.5, the top DNA band shifted slower as the amount of YdiV increased, indicating the formation of larger complexes. More interestingly, when the gel was dyed with Coomassie brilliant blue, protein bands that could not be dyed with EB appeared at much slower positions in the gel. This unexpected phenomenon suggests that YdiV at different stoichiometry to FlhD4C2 leads to various effects on DNA binding of FlhD4C2. We thus speculate that YdiV can form a variety of complexes with FlhD4C2 (YdiV1–FlhD4C2, YdiV2–FlhD4C2, YdiV3–FlhD4C2 and YdiV4–FlhD4C2), in which YdiV1–FlhD4C2 and YdiV2–FlhD4C2 can still bind to DNA, while YdiV3–FlhD4C2 and YdiV4–FlhD4C2 lose DNA-binding ability. But this raises more questions such as why YdiV forms so many kinds of complexes with FlhDC and how it inhibits FlhD4C2 binding to DNA in a concentration dependent manner.
Structure of YdiV–FlhD complex shows a heterotetramer
In order to elucidate the molecular mechanism by which YdiV regulates DNA-binding ability of FlhD4C2 complex, we embarked on structure determination of YdiV–FlhDC complex by x-ray crystallography. However, perhaps due to the structural heterogeneity of YdiV–FlhDC complex, numerous screening for the crystallization failed to give a hit. Despite this difficulty, we crystallized the YdiV–FlhD complex successfully. The structure was determined at 2.9 Å resolution with the molecular replacement approach using the FlhD structure (PDB code: 1G8E) and our YdiV structure as searching models. The final model contains four YdiV molecules (Mols A, C, E and G) and four FlhD molecules (Mols B, D, F and H) in the asymmetric unit, with each YdiV interacting with one corresponding FlhD in a uniform binding manner. Owing to limited proteolysis, some residues are missing. Two hundred and six residues (11–33 and 51–233) were built for YdiV and 81 residues (1–81) were built for FlhD.
The interaction interface analysis using CCP4 showed that the YdiV–FlhD complex may form a stable tetramer (Mol ABHG or Mol CDFE) in solution through a tightly coupled FlhD dimer core (Mol BH or Mol DF) (Figure 3A). The dimerization pattern of FlhD in the YdiV–FlhD complex is very similar to that of FlhD homodimers (PDB code:1G8E), where residues Cys 65/B and Cys 65/H are connected by a disulfide bond (45). The size-exclusion chromatography results also showed that YdiV–FlhD complex exists as tetramer in solution (Supplementary Figure S5). Figure 3B illustrates details of the YdiV–FlhD interface using Mol A and Mol B as example. The interface spans 973 Å2, which accounts for nearly 10% of the total YdiV surface area and 15% of FlhD. It consists of α6, α7 and α8 of YdiV and α1 and α4 of FlhD which constitutes hydrogen bonds, salt bridges and hydrophobic interactions. Residues Phe155, Phe168, His175, Glu179, Phe181, Arg183 and Gln188 of YdiV and Lys8, Tyr11, Asp12, Leu15, Leu19, Arg23, Val26, Leu51, Val55 and Glu59 of FlhD directly participate in the interaction and compose a highly firm interface (Figure 3C). Remarkably, α8 (176–192) of YdiV parallelizes and intensively interacts with α4 (5–26) of FlhD, providing most of the interacting residues. Side chains of three aromatic residues (Phe155, Phe168 and Phe181) from YdiV anchor onto α1 and α4 in the adjacent hydrophobic pockets of FlhD and form a hydrophobic core at the center of the molecular interface. The interface is further secured by a network of polar contacts: His175Y/Glu59F, Glu179Y/Lys8F and Arg183Y/Aap12F. Compared with their single structures, YdiV and FlhD do not show significant conformational change even in the interface region. However, the side chains of the essential residues (His175, Glu179, Phe181 and Arg183) of YdiV, which mediate the interactions, show obvious deflection (Supplementary Figure S6). Very recently, Takaya et al. reported that the L22H substitution in FlhD prevents its interaction with YdiV. Leu22 of Salmonella FlhD, which is Leu19 of E. coli FlhD in our structure, is located in the interface of YdiV–FlhD. The side chain of His is hydrophilic and larger than Leu, so it may interrupt the interaction between these two proteins (32).
Moreover, sequence alignment shows that the key residues (Phe155, Phe168, Phe181 and Ala184) of YdiV involved in the interface are highly conserved across E. coli and other Enterobacteriaceae group orthologs (Figure 3D and E). As we input six sequences including YdiV and its orthologs into the motif prediction tool MEME suite, three conserved motifs with about 20 residues were detected and two of them were located within the interface. The high conservation of residues composing the interface of YdiV and FlhD across Enterobacteriaceae group suggests that YdiV from other Enterobacteriaceae group members may also interact with FlhD in the same way and down-regulate flagella biogenesis and motility.
YdiV can squeeze into the ring-like structure of FlhD4C2 complex
YdiV forms stable heterotetramer with FlhD and can form quaternary complex with FlhD4C2 through interacting with FlhD. Why can it form a variety of complex with FlhD4C2 in a concentration-dependent manner? In order to explain this phenomenon, we superimposed the FlhD subunit in the YdiV–FlhD model onto the four FlhD subunit in FlhD4C2 model, respectively (Figure 4). Very surprisingly, the four FlhD subunits of FlhD4C2 adopt different structures. The α1 and α4 of the two peripheral FlhD subunits which compose the main part of the binding interface with YdiV are exposed. These two α-helices of the two internal FlhD subunits are completely buried in the central interface. In this means, only the two peripheral FlhD subunits of FlhD4C2 are accessible for YdiV binding without affecting the integrity of FlhD4C2 complex. So we speculate at low stoichiometry, YdiV binds sequentially to the two peripheral FlhD subunits to form two kinds of quaternary complexes (YdiV1–FlhD4C2 or YdiV2–FlhD4C2 shown in Figure 5A and B). With the increase of the ratio of YdiV, the exposed sites of FlhD for YdiV to bind are saturated. Hereafter, YdiV has to squeeze into the ring-like structure of FlhD4C2 in order to bind to the internal FlhD subunits, which destroys the interface between the central FlhD subunits and leads to significant structural reorganization of the protein complex (Figure 5C and D). At this stage, two kinds of quaternary complexes (YdiV3–FlhD4C2 or YdiV4–FlhD4C2) could form. As the ratio of YdiV keeps increasing, the internal binding sites of FlhD for YdiV are eventually saturated and the final product becomes YdiV4–FlhD4C2.
When the FlhD4C2 complex is saturated by YdiV, two YdiV molecules will squeeze into the ring-like structure. Severe steric hindrance has to be overcome during this process (Figure 5D). The associated significant structural reorganization of the protein complex raises a question whether the YdiV4–FlhD4C2 complex exists stably in solution. In order to answer this question, we performed size-exclusion chromatography (Figure 6). YdiV and FlhD4C2 were mixed at molar ratios of 5:1, 4:1, 3:1, 2:1 or 1:1 and loaded onto a size-exclusion column. Single YdiV or FlhD4C2 was examined in the same condition as control. The YdiV–FlhD4C2 mixture with the molar ratio of 1:1 had a single elution peak at a position (14.59 ml) larger than FlhD4C2 hexamer (15.09 ml) (SDS–PAGE result of elution solution shown in Figure 6B). As the YdiV proportion increased, the elution peak of the mixtures came out earlier from the column until reached at 13.31 ml. The 5:1 YdiV–FlhD4C2 mixture showed two peaks (13.31 and 16.50 ml) indicating the presence of excessive amount of free YdiV in the system. Figure 6C showed gel result of elution samples of 5:1 YdiV–FlhD4C2 mixture: the first peak was FlhD4C2Y4 complex; the second one was excessive YdiV. Mixtures of YdiV and FlhD4C2 at different proportions were also analyzed using Source-Q column (Supplementary Figure S7). The YdiV4–FlhD4C2 complex was eluted as a single peak at the conductance around 16.1 mS/cm. All the observations indicated that the binding of four YdiV molecules does not lead to the dissociation of FlhD4C2, and heterodecameric YdiV4–FlhD4C2 complex exists stably in solution.
DNA binds the FlhD4C2 complex through wrapping around FlhC subunits and the YdiV4–FlhD4C2 complex loses ring-like structure and DNA-binding ability
Our results show that YdiV can form a variety of complex with FlhD4C2. Then why can YdiV1–FlhD4C2 and YdiV2–FlhD4C2 still bind to DNA, whereas YdiV3–FlhD4C2 and YdiV4–FlhD4C2 lose DNA-binding ability? The crystal structure of the FlhD4C2 shows two zinc-binding sites located close to the interface of FlhD and FlhC. However, the DNA-binding manner remains unclear (8). If DNA wraps around FlhD subunits, YdiV should displace DNA from the FlhD4C2 complex when YdiV1–FlhD4C2 or YdiV2–FlhD4C2 complex are formed. Why is the DNA fragment released only when more YdiV molecules incorporate into the complex? Vacuum electrostatic analysis of FlhD4C2 displays a large positively charged region on each FlhC subunit (Figure 7A). The positively charged region on FlhD subunit is much smaller than on FlhC subunit indicating that FlhC may be more competitive than FlhD in binding to the negatively charged DNA. Thus, we designed three mutants (DCmut-1, DCmut-2 and DCmut-3) of FlhC to verify the DNA-binding mechanism. Lys42 and Lys45 of FlhC were substituted by Glu in DCmut-1; DCmut-2 contains four substitutions (R37E, R39E, K42E and K45E). DCmut-3 (I6D, V7D and E7A) was designed to destroy the dimerization interface of FlhC in FlhD4C2. During purification, the FlhDC mutants behave similarly to the wild-type FlhDC complex (Supplementary Figure S8). DCmut-1 and DCmut-2 possess similar secondary structure with native FlhDC complex while DCmut-3 presents a little difference when determined by circular dichroism spectroscopy. Pull-down assays showed that all FlhDC mutants can still interact with YdiV. The elution volume of DCmut-3 was larger than the wild-type FlhDC complex and other two mutants, indicating that DCmut-3 fails to dimerize in solution.
EMSA was used to detect the DNA–protein interaction with the 49-bp promoter region of flhB used as the target DNA. When the ratio of wild-type FlhDC and DNA exceeds 1:1, FlhDC-DNA complex can be detected (Figure 7B). Compared with the wild-type FlhDC protein, DCmut-1 and DCmut-2, whose basic residues (R37, R39, K42 and K45) were substituted by polar acidic ones, cannot bind DNA anymore even with 16-fold excess (Figure 7C and D). DCmut-3 also entirely abolished FlhDC’s DNA-binding ability (Figure 7E).
Previous studies showed that FlhD did not bind to DNA, while FlhC bound to DNA independently but with a binding affinity less than one-tenth of FlhD4C2 (6,7). Both DCmut-1 and DCmut-2 lost the ability of DNA binding, indicating that the selected amino acid residues on FlhC play an irreplaceable role in DNA binding. Furthermore, DCmut-3, which was constructed to break the interface of FlhC dimer and to destroy the ring-like structure of FlhD4C2, also did not bind to DNA even in a 32-fold excess. Our data strongly suggest that target DNA directly interacts with the positive-charge-enriched region of FlhC, while FlhD is essential for DNA binding by keeping the ring-like structure of FlhD4C2.
Given the above-mentioned data, we can explain how YdiV regulates DNA binding of FlhD4C2 in a concentration-dependent manner. The FlhD4C2 complex recruits DNA through the Zn-Cys cluster and the positive-charge-enriched region of FlhC dimer. In this process, the ring-like structure of FlhD4C2 is indispensable. Through the interaction with FlhD, YdiV can form a variety of complexes with FlhD4C2. At low stoichiometric concentration, YdiV only binds to the offside of FlhD4C2 and do not affect DNA-binding affinity of FlhD4C2. At high stoichiometric concentration, the third and fourth YdiV molecules squeeze into the ring-like structure of FlhD4C2 and induce structure rearrangement. So the DNA-binding site is no longer suitable for DNA binding.
To confirm that the YdiV4–FlhD4C2 complex lost ring-like structure, we performed negative staining EM of YdiV4–FlhD4C2 complex. Indeed, two-dimensional class averages of YdiV4–FlhD4C2 complexes showed various conformations, among which both half-opened and wide-opened YdiV4–FlhD4C2 complexes were observed (Figure 8). As a control, FlhD4C2 without YdiV showed integral ring-like structure.
YdiV mutants do not bind to FlhD, affect the DNA binding of FlhD4C2 or inhibit cell motility in vivo
Mutagenesis was employed to validate the results of structure analysis. Eight residues (Phe155, Phe168, His175, Glu179, Phe181, Arg183, Ala184 and Gln188) of YdiV are in contact with FlhD. Most of the interacting residues are located on α8 (176–192aa), which parallelizes and intensively interacts with α4 (5–26aa) of FlhD. We constructed 12 mutants for YdiV and investigated their binding abilities with FlhD.
Residue Ala184 is situated at the center of α8 of YdiV and is next to Asp12 of FlhD in the YdiV–FlhD complex. The A184E mutant completely destroyed the interaction through its oversized side chain and the repulsion to Asp12 of FlhD. This also happened with the double-point mutant F181A–A184E. Another six mutants, F155A, F168A, F168Q, F181S, F181Q and F181A, exhibited reduced affinities to FlhD in varying degrees (Figure 9A).
We also examined the interactions between YdiV mutants and FlhD4C2. The mutants (F155A, F168A, F168Q, F181S, F181Q, F181A, F181A-A184E and A184E) that are weak in binding FlhD also showed decreased FlhDC-binding affinities in the same degree as with FlhD (Figure 9B). We went on to examine the inhibitory function of YdiV mutants to the DNA-binding activity of FlhD4C2 with EMSA. The F181A-A184E mutant, which did not bind to FlhD and FlhD4C2, lost their inhibitory function entirely; the mutants with weak binding affinity to FlhD/FlhD4C2 revealed decreased inhibitory function. These observations indicate that there is an evidential correlation between the FlhD/FlhD4C2-binding affinity and the inhibitory function among YdiV mutants (Figure 9C).
We further compared the motility behavior of wild-type E. coli and the ones overexpressing YdiV or its mutants on soft agar plates. The size of the zone of swimming by the YdiV overexpressed strain (YdiV OE) was much smaller than wild-type strain, indicating that YdiV inhibits cell motility in E. coli (Figure 9D). In comparison, strains that overexpress three mutants (F181A, F181A–A184E and A184E) of YdiV, respectively, all showed similar ability of motility with control strain that harbors GST overexpression (Figure 9E and F).
Our data suggest that the anti-FlhD4C2 function of YdiV is directly caused by FlhD binding: the YdiV mutants’ lack of FlhD-binding ability also lose all their inhibitory function to FlhD4C2’s DNA-binding affinity and therefore do not inhibit cell motility in vivo; the mutants with decreased binding affinity to FlhD also decrease their inhibitory function to the cell motility in the same degree.
DISCUSSION
EAL proteins are known to be dimer in solution and catalyze the hydrolysis of c-di-GMP. In this regard, YdiV is an outlier of the family. Sequence analysis shows that 8 out of the 10 conserved catalytic residues are not preserved. Structure analysis indicates that, due to the key residue changes, the potential substrate binding site is no longer compatible for c-di-GMP binding. More importantly, the α8 (176–192) of YdiV differs from typical EAL proteins extensively and abolishes the dimerization activity. Ironically, it is the α8 (176–192) of YdiV that makes the greatest contribution to the interaction with FlhD. Previous bioinformatics studies have showed that 450 out of 1805 EAL-only proteins lack key catalytic residues and do not hydrolyze c-di-GMP (46). Similar to YdiV, those unconventional EAL proteins may not function in c-di-GMP turnover (47).
It has been reported that YdiV can mediate the interaction between the two quorum-sensing systems in E. coli in cooperation with its transcription activators SdiA and cAMP (30). This raises a question if there is a crosstalk between quorum-sensing systems and FlhDC transcriptional activity through YdiV (Supplementary Figure S9). Although YdiV cannot bind to c-di-GMP, a large hydrophobic groove is still observed at the potential active site. Electron density map clearly shows the existence of a phosphate and a glycerol molecule in this groove. Thus, small molecules, such as cGMP or cAMP, may bind to YdiV. It is reasonable to expect that binding of ligand may induce significant conformational changes around the active site of YdiV. α6, α7 and α8 of YdiV located around the binding groove could be affected during this process. Consequently, YdiV may lose binding affinity to the FlhD4C2 complex.
The FlhD4C2 complex contains four YdiV-binding sites. Two of them are exposed and ready for YdiV binding. The other two sites are buried within the ring-like structure. YdiV squeezes into the ring-like structure to occupy these two sites only when its concentration reaches a certain threshold and saturates the exposed binding sites of FlhD. We have proved that DNA binds the FlhD4C2 complex through wrapping around FlhC subunits rather than FlhD subunits. Occupation of the two peripheral binding sites by YdiV does not affect the DNA-binding ability of FlhD4C2 complex.
Our work shows that only when the molar ratio of YdiV:FlhD4C2 is higher than two, DNA begins to be displaced from the transcriptor complex. The unique mechanism by which YdiV regulates the FlhD4C2 complex also raises questions if this threshold really exists in vivo and if bacteria can benefit from the concentration-dependent mechanism. So far, real-time monitoring of the intracellular concentration of YdiV, FlhD4C2 and the varieties of related complexes turned out to be very difficult. However, we can expect that, if the YdiV concentration threshold really exists in vivo, it would benefit the bacteria. Flagella biogenesis is an energy-consuming and time-consuming process. The switch between the motile and sessile lifestyles is a significant decision for bacteria. In order to prevent unnecessary energy waste, it is better for the bacteria not to switch on or off the corresponding gene transcription too frequently while the external environment is always changing rapidly. Very likely, when the related signal is strong enough and maintains long enough, the intracellular concentration of YdiV slowly accumulates to a certain level for the flagellum biogenesis to begin to decrease. Only when intracellular concentration of YdiV is high enough to saturate all FlhD4C2 complex, is the biogenesis shut down completely. It appears that the best choice for bacteria is to change their lifestyle only when they have to.
Takaya et al. (32) have recently reported that YdiV not only strips FlhD4C2 from DNA but also facilitates ClpXP protease-mediated FlhD4C2 degradation. In this regard, when the intracellular concentration of YdiV reaches a threshold, the breakage of the ring-like structure of FlhD4C2 complex will make YdiV4–FlhD4C2 available to be degraded by ClpXP protease.
On the basis of our data and previous reports, we propose a model in which YdiV negatively regulates transcriptional activity of FlhD4C2. In the beginning, FlhD4C2 binds to the promoter region of flagellar operons and the corresponding genes remain being transcribed. Then the expression of YdiV is triggered by external signal, and YdiV protein starts to bind to the peripheral binding sites of FlhD4C2. At this stage, gene transcription is not affected. However, if the external signal is strong enough and maintains long enough, the intracellular YdiV concentration eventually reaches a threshold and YdiV begins to squeeze into the ring-like structure of FlhD4C2 complex. Finally, DNA is displaced from the FlhD4C2, and FlhD4C2 is degraded by ClpXP protease. As a result, the subsequent expression of flagellar genes is repressed and motility is stopped (Figure 10).
ACCESSION NUMBERS
Coordinate and structure factor files of YdiV and YdiV–FlhDC have been deposited in the Protein Data Bank (http://www.rcsb.org/pdb) under ID codes 3TLQ and 4ES4, respectively.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online: Supplementary Table 1, Supplementary Figures 1–9, Supplementary Methods, Supplementary References [33–40].
FUNDING
Hi-Tech Research and Development Program of China [2006AA02A324]; National Natural Science Foundation of China [31270786 to L.G.]; National Basic Research Program of China [2010CB912401 to H.-W.W.]. Funding for open access charge: National Natural Science Foundation of China [31270786 to L.G.].
Conflict of interest statement. None declared.
Supplementary Material
ACKNOLEDGEMENTS
E. coli str. K-12 substr. MG1655 and plasmids for gene knochout are gifts from Prof. Qingsheng Qi. We thank the staff at the beamline BL17U1 at the Shanghai Synchrotron Radiation Facility for supporting with the data collection.
REFERENCES
- 1.Aldridge P, Hughes KT. Regulation of flagellar assembly. Curr. Opin. Microbiol. 2002;5:160–165. doi: 10.1016/s1369-5274(02)00302-8. [DOI] [PubMed] [Google Scholar]
- 2.Chevance FF, Hughes KT. Coordinating assembly of a bacterial macromolecular machine. Nat. Rev. Microbiol. 2008;6:455–465. doi: 10.1038/nrmicro1887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liu X, Matsumura P. The FlhD/FlhC complex, a transcriptional activator of the Escherichia coli flagellar class II operons. J. Bacteriol. 1994;176:7345–7351. doi: 10.1128/jb.176.23.7345-7351.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pruss BM, Campbell JW, Van Dyk TK, Zhu C, Kogan Y, Matsumura P. FlhD/FlhC is a regulator of anaerobic respiration and the Entner–Doudoroff pathway through induction of the methyl-accepting chemotaxis protein Aer. J. Bacteriol. 2003;185:534–543. doi: 10.1128/JB.185.2.534-543.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Claret L, Hughes C. Functions of the subunits in the FlhD(2)C(2) transcriptional master regulator of bacterial flagellum biogenesis and swarming. J. Mol. Biol. 2000;303:467–478. doi: 10.1006/jmbi.2000.4149. [DOI] [PubMed] [Google Scholar]
- 6.Claret L, Hughes C. Interaction of the atypical prokaryotic transcription activator FlhD2C2 with early promoters of the flagellar gene hierarchy. J. Mol. Biol. 2002;321:185–199. doi: 10.1016/s0022-2836(02)00600-9. [DOI] [PubMed] [Google Scholar]
- 7.Wang S, Fleming RT, Westbrook EM, Matsumura P, McKay DB. Structure of the Escherichia coli FlhDC complex, a prokaryotic heteromeric regulator of transcription. J. Mol. Biol. 2006;355:798–808. doi: 10.1016/j.jmb.2005.11.020. [DOI] [PubMed] [Google Scholar]
- 8.Soutourina O, Kolb A, Krin E, Laurent-Winter C, Rimsky S, Danchin A, Bertin P. Multiple control of flagellum biosynthesis in Escherichia coli: role of H-NS protein and the cyclic AMP-catabolite activator protein complex in transcription of the flhDC master operon. J. Bacteriol. 1999;181:7500–7508. doi: 10.1128/jb.181.24.7500-7508.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wei BL, Brun-Zinkernagel AM, Simecka JW, Pruss BM, Babitzke P, Romeo T. Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli. Mol. Microbiol. 2001;40:245–256. doi: 10.1046/j.1365-2958.2001.02380.x. [DOI] [PubMed] [Google Scholar]
- 10.Francez-Charlot A, Laugel B, Van Gemert A, Dubarry N, Wiorowski F, Castanie-Cornet MP, Gutierrez C, Cam K. RcsCDB His-Asp phosphorelay system negatively regulates the flhDC operon in Escherichia coli. Mol. Microbiol. 2003;49:823–832. doi: 10.1046/j.1365-2958.2003.03601.x. [DOI] [PubMed] [Google Scholar]
- 11.Tomoyasu T, Takaya A, Isogai E, Yamamoto T. Turnover of FlhD and FlhC, master regulator proteins for Salmonella flagellum biogenesis, by the ATP-dependent ClpXP protease. Mol. Microbiol. 2003;48:443–452. doi: 10.1046/j.1365-2958.2003.03437.x. [DOI] [PubMed] [Google Scholar]
- 12.Takaya A, Matsui M, Tomoyasu T, Kaya M, Yamamoto T. The DnaK chaperone machinery converts the native FlhD2C2 hetero-tetramer into a functional transcriptional regulator of flagellar regulon expression in Salmonella. Mol. Microbiol. 2006;59:1327–1340. doi: 10.1111/j.1365-2958.2005.05016.x. [DOI] [PubMed] [Google Scholar]
- 13.Yamamoto S, Kutsukake K. FliT acts as an anti-FlhD2C2 factor in the transcriptional control of the flagellar regulon in Salmonella enterica serovar typhimurium. J. Bacteriol. 2006;188:6703–6708. doi: 10.1128/JB.00799-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wada T, Morizane T, Abo T, Tominaga A, Inoue-Tanaka K, Kutsukake K. EAL domain protein YdiV acts as an anti-FlhD4C2 factor responsible for nutritional control of the flagellar regulon in Salmonella enterica Serovar Typhimurium. J. Bacteriol. 2011;193:1600–1611. doi: 10.1128/JB.01494-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Imada K, Minamino T, Kinoshita M, Furukawa Y, Namba K. Structural insight into the regulatory mechanisms of interactions of the flagellar type III chaperone FliT with its binding partners. Proc. Natl Acad. Sci. USA. 2010;107:8812–8817. doi: 10.1073/pnas.1001866107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Schmidt AJ, Ryjenkov DA, Gomelsky M. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 2005;187:4774–4781. doi: 10.1128/JB.187.14.4774-4781.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tamayo R, Tischler AD, Camilli A. The EAL domain protein VieA is a cyclic diguanylate phosphodiesterase. J. Biol. Chem. 2005;280:33324–33330. doi: 10.1074/jbc.M506500200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rao F, Yang Y, Qi Y, Liang ZX. Catalytic mechanism of cyclic di-GMP-specific phosphodiesterase: a study of the EAL domain-containing RocR from Pseudomonas aeruginosa. J. Bacteriol. 2008;190:3622–3631. doi: 10.1128/JB.00165-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Simm R, Morr M, Kader A, Nimtz M, Romling U. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol. 2004;53:1123–1134. doi: 10.1111/j.1365-2958.2004.04206.x. [DOI] [PubMed] [Google Scholar]
- 20.Hengge R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 2009;7:263–273. doi: 10.1038/nrmicro2109. [DOI] [PubMed] [Google Scholar]
- 21.Schirmer T, Jenal U. Structural and mechanistic determinants of c-di-GMP signalling. Nat. Rev. Microbiol. 2009;7:724–735. doi: 10.1038/nrmicro2203. [DOI] [PubMed] [Google Scholar]
- 22.Romling U. Rationalizing the evolution of EAL domain-based cyclic di-GMP-specific phosphodiesterases. J. Bacteriol. 2009;191:4697–4700. doi: 10.1128/JB.00651-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Tchigvintsev A, Xu X, Singer A, Chang C, Brown G, Proudfoot M, Cui H, Flick R, Anderson WF, Joachimiak A, et al. Structural insight into the mechanism of c-di-GMP hydrolysis by EAL domain phosphodiesterases. J. Mol. Biol. 2010;402:524–538. doi: 10.1016/j.jmb.2010.07.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hisert KB, MacCoss M, Shiloh MU, Darwin KH, Singh S, Jones RA, Ehrt S, Zhang Z, Gaffney BL, Gandotra S, et al. A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic diGMP. Mol. Microbiol. 2005;56:1234–1245. doi: 10.1111/j.1365-2958.2005.04632.x. [DOI] [PubMed] [Google Scholar]
- 25.Simm R, Remminghorst U, Ahmad I, Zakikhany K, Romling U. A role for the EAL-like protein STM1344 in regulation of CsgD expression and motility in Salmonella enterica serovar Typhimurium. J. Bacteriol. 2009;191:3928–3937. doi: 10.1128/JB.00290-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Simms AN, Mobley HL. Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J. Bacteriol. 2008;190:3747–3756. doi: 10.1128/JB.01870-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wozniak CE, Lee C, Hughes KT. T-POP array identifies EcnR and PefI-SrgD as novel regulators of flagellar gene expression. J. Bacteriol. 2009;191:1498–1508. doi: 10.1128/JB.01177-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Zhao K, Liu M, Burgess RR. Adaptation in bacterial flagellar and motility systems: from regulon members to ‘foraging’-like behavior in E. coli. Nucleic Acids Res. 2007;35:4441–4452. doi: 10.1093/nar/gkm456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wada T, Hatamoto Y, Kutsukake K. Functional and expressional analyses of the anti-FlhD4C2 factor gene ydiV in Escherichia coli. Microbiology. 2012;158:1533–1542. doi: 10.1099/mic.0.056036-0. [DOI] [PubMed] [Google Scholar]
- 30.Zhou X, Meng X, Sun B. An EAL domain protein and cyclic AMP contribute to the interaction between the two quorum sensing systems in Escherichia coli. Cell Res. 2008;18:937–948. doi: 10.1038/cr.2008.67. [DOI] [PubMed] [Google Scholar]
- 31.Stewart MK, Cummings LA, Johnson ML, Berezow AB, Cookson BT. Regulation of phenotypic heterogeneity permits Salmonella evasion of the host caspase-1 inflammatory response. Proc. Natl Acad. Sci. USA. 2011;108:20742–20747. doi: 10.1073/pnas.1108963108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Takaya A, Erhardt M, Karata K, Winterberg K, Yamamoto T, Hughes KT. YdiV: a dual function protein that targets FlhDC for ClpXP-dependent degradation by promoting release of DNA-bound FlhDC complex. Mol. Microbiol. 2012;83:1268–1284. doi: 10.1111/j.1365-2958.2012.08007.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Method Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- 34.Terwilliger TC, Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D. Biol. Crystallogr. 1999;55:849–861. doi: 10.1107/S0907444999000839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Terwilliger TC. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 2000;56:965–972. doi: 10.1107/S0907444900005072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 37.Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Read RJ, Sacchettini JC, Sauter NK, Terwilliger TC. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 2002;58:1948–1954. doi: 10.1107/s0907444902016657. [DOI] [PubMed] [Google Scholar]
- 38.McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 2007;157:38–46. doi: 10.1016/j.jsb.2006.05.009. [DOI] [PubMed] [Google Scholar]
- 40.van Heel M, Harauz G, Orlova EV, Schmidt R, Schatz M. A new generation of the IMAGIC image processing system. J. Struct. Biol. 1996;116:17–24. doi: 10.1006/jsbi.1996.0004. [DOI] [PubMed] [Google Scholar]
- 41.Barends TR, Hartmann E, Griese JJ, Beitlich T, Kirienko NV, Ryjenkov DA, Reinstein J, Shoeman RL, Gomelsky M, Schlichting I. Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase. Nature. 2009;459:1015–1018. doi: 10.1038/nature07966. [DOI] [PubMed] [Google Scholar]
- 42.Minasov G, Padavattan S, Shuvalova L, Brunzelle JS, Miller DJ, Basle A, Massa C, Collart FR, Schirmer T, Anderson WF. Crystal structures of YkuI and its complex with second messenger cyclic Di-GMP suggest catalytic mechanism of phosphodiester bond cleavage by EAL domains. J. Biol. Chem. 2009;284:13174–13184. doi: 10.1074/jbc.M808221200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Navarro MV, De N, Bae N, Wang Q, Sondermann H. Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX. Structure. 2009;17:1104–1116. doi: 10.1016/j.str.2009.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Navarro MV, Newell PD, Krasteva PV, Chatterjee D, Madden DR, O'Toole GA, Sondermann H. Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol. 2011;9:e1000588. doi: 10.1371/journal.pbio.1000588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Campos A, Zhang RG, Alkire RW, Matsumura P, Westbrook EM. Crystal structure of the global regulator FlhD from Escherichia coli at 1.8 A resolution. Mol. Microbiol. 2001;39:567–580. doi: 10.1046/j.1365-2958.2001.02247.x. [DOI] [PubMed] [Google Scholar]
- 46.Romling U, Amikam D. Cyclic di-GMP as a second messenger. Curr. Opin. Microbiol. 2006;9:218–228. doi: 10.1016/j.mib.2006.02.010. [DOI] [PubMed] [Google Scholar]
- 47.Seshasayee AS, Fraser GM, Luscombe NM. Comparative genomics of cyclic-di-GMP signalling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res. 2010;38:5970–5981. doi: 10.1093/nar/gkq382. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.